|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
REVIEW |
B Hoffman, Cancer Endocrinology, BC Cancer Research Center, Vancouver, British Columbia, Canada
S Jones, Micheal Smith Genome Sciences Centre, Vancouver, V5Z 4S6, Canada
Correspondence: Steven Jones, Email: sjones{at}bcgsc.ca
Abstract
The transcriptional networks underlying mammalian cell development and function are largely unknown. The recently described use of flow cell sequencing devices in combination with chromatin immunoprecipitation (ChIP-seq) stands to revolutionize the identification of DNA-protein interactions. As such, ChIP-seq is rapidly becoming the method of choice for the genome wide localization of histone modifications and transcription factor binding sites. As further studies are performed, the information generated by ChIP-seq is expected to allow the development of a framework for networks describing the transcriptional regulation of cellular development and function. However, to date this technology has been only applied to a small number of cell types, and even fewer tissues, suggesting a huge potential for novel discovery in this field.
This article has been cited by other articles:
![]() |
K J Dudley, K Revill, R N Clayton, and W E Farrell Pituitary tumours: all silent on the epigenetics front J. Mol. Endocrinol., June 1, 2009; 42(6): 461 - 468. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH |